The NZX needs an energetic, determined and inspirational chairman to reverse the performance of the past few decades.
There are plenty of reasons to be nervous about 2022, but maybe that's not a bad thing.
The Chinese infant formula market space is looking increasingly unattractive and multinationals are selling out not buying in.
A $450 million injection of cash will allow the company to accelerate the development of the sixth generation of its electric vertical take-off and landing aircraft.